ABSCIENCES (EPA:AB) | Finanzwire

Basculer en Français

9476	Companies
185464	Keywords
117811	Articles
99314	Press releases

Home
Companies
ABSCIENCES

BRIEF

published on 04/23/2025 at 19:04, 7 months 11 days ago

EMA Grants Orphan Drug Status to AB8939 for AML Treatment

AB Science AB8939 EMA Approval Acute Myeloid Leukemia Orphan Designation
PRESS RELEASE

published on 04/23/2025 at 18:59, 7 months 11 days ago

AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety

Orphan Drug Designation AB Science EMA AB8939 Acute Myeloid Leukemia
BRIEF

published on 03/04/2025 at 08:40, 9 months 1 day ago

Masitinib Emerges as Potential Game-Changer in MS Treatment

AB Science Masitinib Neuroinflammation Progressive MS Patrick Vermersch
PRESS RELEASE

published on 03/04/2025 at 08:35, 9 months 1 day ago

AB Science: Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
AB Science's masitinib and its phase 3 principal investigator, neurologist Patrick Vermersch, featured in Life Sciences Magazine for potential breakthrough in Progressive MS Treatment

AB Science Masitinib Patrick Vermersch Life Sciences Magazine Progressive MS Treatment
BRIEF

published on 01/29/2025 at 19:08, 10 months 6 days ago

AB Science Updates on Masitinib Platform Progress

Multiple Sclerosis Masitinib Platform ALS Study Alzheimer’s Treatment AB Science Strategy
PRESS RELEASE

published on 01/29/2025 at 19:03, 10 months 6 days ago

AB Science today provides an update on its masitinib platform
AB Science provides update on masitinib platform for ALS, MS, and AD. Positive results show potential for huge market sales. Debt negotiation planned

Update AB Science Masitinib Platform Market Sales Debt Negotiation
BRIEF

published on 01/24/2025 at 18:06, 10 months 11 days ago

AB Science to Present Masitinib Update in Upcoming Webcast

Pharmaceuticals Webcast Research Update AB Science Masitinib
PRESS RELEASE

published on 01/24/2025 at 18:01, 10 months 11 days ago

AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET
AB Science to host live webcast on masitinib platform update on January 28, 2025, 5.30pm CET. Leading pharmaceutical company specializing in protein kinase inhibitors

Pharmaceutical Company Live Webcast AB Science Protein Kinase Inhibitors Masitinib Platform
BRIEF

published on 01/22/2025 at 19:04, 10 months 13 days ago

AB Science Participates in Biomed Forum Investors Conference

Investor Conference BIOMED Forum AB Science Masitinib Protein Kinase Inhibitors
PRESS RELEASE

published on 01/22/2025 at 18:59, 10 months 13 days ago

AB Science will participate in the Biomed Forum investors conference
AB Science to participate in Biomed Forum Investors Conference organized by AllInvest Securities in Paris on February 4, 2025

Pharmaceutical Company BIOMED Forum AB Science Investors Conference AllInvest Securities

Accesswire

Published on 12/05/2025 at 14:00, 19 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 19 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 44 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 49 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 19 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 34 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 19 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 19 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 14 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 19 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 34 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 19 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 34 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 35 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE